SAN DIEGO, Nov. 14, 2024 /PRNewswire/ -- HUYABIO International today announced the presentation of new patient data for HBI-3000, an antiarrhythmic drug (AAD) with a unique protective profile for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback